Screener
Ironwood Pharmaceuticals IRWD EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from Ironwood Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: Ironwood Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091987
FAQ
- What is Ironwood Pharmaceuticals's EBITDA margin?
- Ironwood Pharmaceuticals (IRWD) reported EBITDA margin of 60.6% in Q2 2026.
- How has Ironwood Pharmaceuticals's EBITDA margin changed year-over-year?
- Ironwood Pharmaceuticals's EBITDA margin increased by 149.7% year-over-year, from 24.3% to 60.6%.
- What is the long-term trend for Ironwood Pharmaceuticals's EBITDA margin?
- Over 5 years (2020 to 2025), Ironwood Pharmaceuticals's EBITDA margin has grown at a -2.1% compound annual growth rate (CAGR), from 37.6% to 33.9%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.
Ask your AI about Ironwood Pharmaceuticals's ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude